project id: TCGA-KIRP; case submitter id: TCGA-AL-3471; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 74; days to birth: -27249; days to death: 1500; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 27249; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1b; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 412.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.6; longest dimension: 0.7; preservation method: Unknown; shortest dimension: 0.3; sample id: 73d58251-83b4-4dd2-85c0-e38fe3044d42; sample submitter id: TCGA-AL-3471-01A; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor nuclei: 80.0;